TTY is the best clinical development partners for oncologists in Taiwan, and cooperates with more than 150 investigators and 29 medical centers. There are 78 TFDA/IRBs submitted/approved phase I to phase III clinical trials conducted/planned from 1996 to April 2014.
- CDMO. TTY has been partnering with global pharmaceutical companies for more than 20 years and has a proven history of successful collaborations. Drawing on our expertise and capabilities in product development and manufacturing, we provide customized services and solutions for starting materials, intermediates, active ingredients and finished dosage forms. GMP-grade functional excipient factory, excellent customization capabilities, outstanding formulation design competence, GMP production, efficient anima
- CRO. TTY Oncology Translational Research Center is dedicated to develop new medical entities, including innovative therapeutic modalities in areas of unmet medical need. We also offer CRO services in pre-clinical drug development by providing in vivo animal studies (conducted in SPF or BSL-2 animal facility), biomarker detection, immunological assays, antibody related assays, bio-analytical assays, and specific method development and qualification. Furthermore, flexible project management ensures time and